Cedars-Sinai Discovery May Aid Doctors in Diagnosing At-risk Patients Before Symptoms Appear
A team led by a Cedars-Sinai physician-scientist has discovered a biomarker—a protein found in the blood—for the most common type of heart failure, a new study published today in JAMA Cardiology shows.
Heart failure with preserved ejection fraction (HFpEF) affects more than 6.5 million Americans each year. And now, thanks to the discovery of the first-ever biomarker for HFpEF, a simple blood test can reveal whether a patient’s heart is not making enough of an important protein. If the protein levels are decreased, the biomarker signal increases and physicians will be able to diagnose heart failure sooner, prescribe corrective medicines and prevent further disease progression.
“By the time heart failure symptoms develop, the critical window for corrective therapy has typically closed,” said Robin Shaw, MD, PhD, the Wasserman Endowed Chair in Cardiology and professor of Medicine at the Smidt Heart Institute at Cedars-Sinai and principal investigator on the study. “Our discovery allows us to not only diagnose the disease sooner, but also to treat patients before that critical period of early intervention for lifesaving care has closed.”
Heart failure with preserved ejection fraction is a condition where the heart can contract, but has problems relaxing—limiting the heart’s ability to fill with blood between each beat—and therefore lowers the amount of blood moving forward with each contraction. Prior to the discovery of the biomarker, clinicians had to wait for patients to have symptoms to make a diagnosis of HFpEF and had to use an echocardiogram that measured how well the heart relaxed. There was no method to gauge the health of the heart muscle before symptoms developed or determine the severity of disease once symptoms were present.
The biomarker—named cBIN1 Score, or CS for short—allows doctors to measure muscle deterioration and measure a protein that regulates the heart’s ability to both contract and relax. As the protein decreases, CS increases, serving as an indication of onset heart failure. The CS biomarker can be measured using a simple blood draw.
This discovery will allow the most at-risk patients—including older patients and patients with high blood pressure, diabetes or dyslipidemia—to be checked during an annual exam from their primary care physician. This pivotal research has the potential to impact millions of people and serve as a critical tool for preventive heart care.
Eduardo Marbán, MD, PhD, director, Smidt Heart Institute
The CS biomarker is designed to be used in an outpatient clinic setting. For patients with known HFpEF, doctors can draw a CS level and use it to both guide current care, including medication adjustments, and predict the chances of a patient being admitted to the hospital in the next 12 months.
“More broadly, this discovery will allow the most at-risk patients—including older patients and patients with high blood pressure, diabetes or dyslipidemia—to be checked during an annual exam from their primary care physician,” said Eduardo Marbán, MD, PhD, director of the Smidt Heart Institute. “This pivotal research has the potential to impact millions of people and serve as a critical tool for preventive heart care.”
Symptoms of heart failure typically appear as fatigue, fluid weight gain, leg swelling and shortness of breath. Heart failure with preserved ejection fraction is typically diagnosed in elderly people or those living with high blood pressure, diabetes, elevated cholesterol, hypertension, obesity, obstructive sleep apnea, anemia, iron deficiency or diabetes. Its prevalence is projected to rise drastically over the coming decades. Previous studies have shown that women represent the majority of patients diagnosed with the disease.
As next steps, Cedars-Sinai researchers plan on identifying specialty populations in which the CS biomarker could be useful, including sex-based differences, those who have undergone a heart transplant or valve replacement, as well as individuals with no known heart disease or risk factors.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- New study shows reversal of heart failure with diabetes drugon November 23, 2020 at 10:33 am
Researchers at the Icahn School of Medicine at Mount Sinai have seen that using a new diabetes drug can help reduce heart failure, according to a recent study.
- Good Sleep Habits Tied to Lower Risk of Heart Failureon November 23, 2020 at 9:25 am
People who slept seven to eight hours a night, didn’t snore and weren’t excessively tired during the day were less likely to develop heart failure.
- Black Americans Suffer More From Heart Disease: The AHA Wants to Change Thaton November 23, 2020 at 7:00 am
The Black Lives Matter movement put racism in the United States under the glare of the public spotlight in 2020. And at its recently concluded annual meeting, the American Heart Association pledged to ...
- Amgen kicks heart failure med back to Cytokinetics after 'GALACTIC' flopon November 23, 2020 at 6:20 am
After more than a decade working on heart failure programs with Cytokinetics, Amgen is handing two programs back to its partner. The move comes after their more advanced program beat placebo in a ...
- Healthy sleepers have far lower heart failure riskon November 23, 2020 at 6:03 am
Regularly getting a good night's sleep can lower your risk of heart failure, regardless of any other risk factors you may have, a new study shows.
- Sufficient Sleep Results in Possible Lower Risk of Heart Failure Among Adultson November 22, 2020 at 4:19 pm
A recent survey of UK Biobank participants showed that healthy sleep habits were associated with a possible lower risk of heart failure among adults, even after adjusting for several confounders.
- Coronavirus in Utah: 3,197 new cases as COVID-19 weekly death toll matches that of heart diseaseon November 22, 2020 at 12:14 pm
On Sunday, the Utah Department of Health reported 3,197 more coronavirus cases, six more deaths, and 74 more hospitalizations in Utah’s growing coronavirus pandemic. The number of cases is a new high ...
- Research on genetic heart disease uncovers new mechanism for heart failureon November 20, 2020 at 4:37 am
Research on genetic heart disease has uncovered a new and unexpected mechanism for heart failure. This landmark discovery found a correlation between the clumping of RNA-binding proteins long linked ...
- Heart Failure Disease Market, Covers Detail Analysis by Types, Applications and Demanding Opportunities till 2025on November 19, 2020 at 6:23 pm
Selbyville, Delaware The Heart Failure Disease market analytical research added to Market Study Report, LLC, is ...
via Bing News